133 related articles for article (PubMed ID: 10377233)
1. Design and synthesis of novel quinoxaline-2,3-dione AMPA/GlyN receptor antagonists: amino acid derivatives.
Nikam SS; Cordon JJ; Ortwine DF; Heimbach TH; Blackburn AC; Vartanian MG; Nelson CB; Schwarz RD; Boxer PA; Rafferty MF
J Med Chem; 1999 Jun; 42(12):2266-71. PubMed ID: 10377233
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
[TBL] [Abstract][Full Text] [Related]
4. 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.
Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
J Med Chem; 1999 Jul; 42(13):2478-84. PubMed ID: 10395489
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
[TBL] [Abstract][Full Text] [Related]
6. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
[TBL] [Abstract][Full Text] [Related]
7. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position.
Takano Y; Shiga F; Asano J; Ando N; Uchiki H; Fukuchi K; Anraku T
Bioorg Med Chem; 2005 Oct; 13(20):5841-63. PubMed ID: 15993606
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 7,8-(methylenedioxy)-1-phenyl-3,5-dihydro-4H-2, 3-benzodiazepin-4-ones as novel and potent noncompetitive AMPA receptor antagonists.
Wang Y; Konkoy CS; Ilyin VI; Vanover KE; Carter RB; Weber E; Keana JF; Woodward RM; Cai SX
J Med Chem; 1998 Jul; 41(14):2621-5. PubMed ID: 9651166
[TBL] [Abstract][Full Text] [Related]
12. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.
Gitto R; Barreca ML; De Luca L; De Sarro G; Ferreri G; Quartarone S; Russo E; Constanti A; Chimirri A
J Med Chem; 2003 Jan; 46(1):197-200. PubMed ID: 12502375
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.
Barreca ML; Gitto R; Quartarone S; De Luca L; De Sarro G; Chimirri A
J Chem Inf Comput Sci; 2003; 43(2):651-5. PubMed ID: 12653534
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of chiral 1-(2'-amino-2'-carboxyethyl)-1,4-dihydro-6,7-quinoxaline-2,3-diones: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor agonists and antagonists.
Sun G; Uretsky NJ; Wallace LJ; Shams G; Weinstein DM; Miller DD
J Med Chem; 1996 Oct; 39(22):4430-8. PubMed ID: 8893837
[TBL] [Abstract][Full Text] [Related]
16. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
Mead AN; Stephens DN
J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
[TBL] [Abstract][Full Text] [Related]
17. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173.
Catarzi D; Colotta V; Varano F; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2001 Sep; 44(19):3157-65. PubMed ID: 11543685
[TBL] [Abstract][Full Text] [Related]
19. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.
Canton T; Böhme GA; Boireau A; Bordier F; Mignani S; Jimonet P; Jahn G; Alavijeh M; Stygall J; Roberts S; Brealey C; Vuilhorgne M; Debono MW; Le Guern S; Laville M; Briet D; Roux M; Stutzmann JM; Pratt J
J Pharmacol Exp Ther; 2001 Oct; 299(1):314-22. PubMed ID: 11561094
[TBL] [Abstract][Full Text] [Related]
20. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
